Search
Blog Post
Women in Science: Emese Zsiros MD, PhD
Blog Post
Cancer Innovations: Prioritizing quality of life while treating cancer
Blog Post
Cancer Innovations: New initiative reduced prescribed opioids by 45%
Clinical Trial
A Phase I First-In-Human, Open-Label, Multicenter Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0505 in Adult Participants with Advanced Solid Tumors
Clinical Trial
A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY FOR LNCB74, A B7-H4 TARGETED ANTIBODY DRUG CONJUGATE, AS MONOTHERAPY IN PARTICIPANTS WITH ADVANCED SOLID TUMORS
Blog Post
Does your gut biome affect your response to immunotherapy?
Clinical Trial
Randomized Phase 2 Clinical Trial of Pembrolizumab Combined with Bevacizumab with or without Agonist Anti-CD40 CDX-1140 in Patients with Recurrent Ovarian Cancer
Blog Post
Coping with hair loss: Jerrolynn's story
Clinical Trial
Randomized Phase 2 Trial of APL-2 with Pembrolizumab vs. APL-2 with Pembrolizumab and Bevacizumab vs. Bevacizumab alone in Patients with Recurrent Ovarian Cancer and Persistent Malignant Effusion
Clinical Trial